Our guide to the issues likely to impact businesses and the key measures taken by African governments in response to COVID-19.
Our life sciences team is one of the largest and most active of any law firm: operating as a single resource across multiple jurisdictions, we combine subject matter experience with a deep knowledge of the sector.
Businesses in the life sciences sector, such as pharmaceutical, biotechnology, medical device, research and diagnostics companies, face important challenges. Taking therapies from the laboratory to the market requires awareness of multiple risks. Other pressures include desire for greater shareholder return, competition in key therapeutic areas, pricing pressures from healthcare payers, regulation beyond core issues, rising R&D costs, operations in emerging markets and aggressive enforcement.
Our life sciences team combines sector-specific and multidisciplinary skills with in-country knowledge to address virtually any business legal requirement. We are already one of the most active law firms in Africa, and we are proud of our legal, scientific and medical knowledge and our awareness of today’s complex commercial, regulatory and enforcement environments.
Local insight, global reach: with teams in 20 African countries, our people understand the business, political, legal, cultural and regulatory issues in the region, and bring those insights to bear on behalf of our clients.
Our global Africa team itself comprises more than 200 lawyers in Johannesburg, Casablanca, London, New York, Paris, Dubai, Perth, Hong Kong and Beijing.
Being part of one of the world's biggest business law firms means we can deliver a fully integrated cross-border business legal service: drawing on numerous legal disciplines to support clients in multijurisdictional issues, transactions and disputes and help them achieve their strategic goals.
Our life sciences team includes award-winning lawyers practicing in compliance and investigations, IP strategy and enforcement, M&A, licensing and distribution, litigation and clinical trials advice. Our capability extends to all other areas required to address risk, including government affairs, environmental law, import/export, tax, real estate and employment law. Many lawyers in our team are former biotech and life sciences professionals, with PhDs and other advanced degrees. Others are former government officials and prosecutors.
Please contact us to discuss how we can help you to achieve your objectives.
DLA Piper Africa achieves impressive results in the newly released 2020 edition of The Legal 500: Europe, Middle East & Africa (EMEA)edition